Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The firm engages in the manufacture and sale of in-vitro diagnostic (IVD) reagents in China. Its product portfolio of IVD reagents consists of male fertility IVD reagents, parasite antibody detection reagents and an EBV antibody detection reagent. The company was founded on August 3, 2017 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company